Literature DB >> 9670321

Regulation of the cell cycle by CDK inhibitors.

T J Soos1, M Park, H Kiyokawa, A Koff.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9670321     DOI： 10.1007/978-3-540-69686-5_5

Source DB:  PubMed          Journal:  Results Probl Cell Differ        ISSN： 0080-1844


× No keyword cloud information.
  4 in total

1.  Hsl1p, a Swe1p inhibitor, is degraded via the anaphase-promoting complex.

Authors:  J L Burton; M J Solomon
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  Karenitecin (bnp1350) and flavopridol as radiosensitizers in malignant glioma.

Authors:  Deepika Rajesh; H Ian Robins; Steven P Howard
Journal:  J Neurol Neuromedicine       Date:  2016

3.  The molecular genetics of breast cancer and targeted therapy.

Authors:  Rachel Suter; James A Marcum
Journal:  Biologics       Date:  2007-09

4.  Tyrosine phosphorylation of the p21 cyclin-dependent kinase inhibitor facilitates the development of proneural glioma.

Authors:  Ellen Hukkelhoven; Yuhui Liu; Nancy Yeh; Daniel Ciznadija; Stacy W Blain; Andrew Koff
Journal:  J Biol Chem       Date:  2012-09-24       Impact factor: 5.157
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.